Immune System Key Ltd.

Immune System Key Ltd. (ISK) is a privately held company that was founded in 2005 by Prof. Uziel Sandler and Dr. Yoram Devary.
It is engaged in discovery and development of innovative treatments for malignant and autoimmune diseases with strong unmet needs. ISK’s assets are based on novel human secreted peptides, which were discovered by the founders. ISK’s lead compound is NerofeTM. NerofeTM was granted by the FDA with orphan drug status for AML treatment and currently is in phase IIa development stage. The company holds 3 worldwide patents on the molecule and applications.

LATEST NEWS

  • download

Nerofe has received a new US patent for metastatic cancer treatment

21 Nov|Comments Off on Nerofe has received a new US patent for metastatic cancer treatment

Phase2a Nerofe study has begun in Rabin and Kaplan medical centers

21 Sep|Comments Off on Phase2a Nerofe study has begun in Rabin and Kaplan medical centers

Phase2a Nerofe study has begun in Rabin and Kaplan medical centers